BioTuesdays on LinkedIn: Cantor starts Editas Medicine at OW; PT …
Cantor Fitzgerald initiated coverage of Editas Medicine (NASDAQ:EDIT) with an “overweight” rating and 12-month price target of $15. The stock closed at $9.35 on Jan. 31 The stock …
OFF
BioTuesdays On LinkedIn: Cantor Starts Editas Medicine At OW; PT …
1 week from now
Cantor Fitzgerald initiated coverage of Editas Medicine (NASDAQ:EDIT) with an “overweight” rating and 12-month price target of $15. The stock closed at $9.35 on Jan. 31 The stock …
linkedin.com
OFF
Stephen Kilmer, Author At BioTuesdays - Page 6 Of 150
1 week from now
Cantor starts Editas Medicine at OW; PT $15. Cantor Fitzgerald initiated coverage of Editas Medicine (NASDAQ:EDIT) with an “overweight” rating and 12-month price target of $15. The …
biotuesdays.com
OFF
BioTuesdays On LinkedIn: Cantor Starts AVITA Medical At OW; PT …
1 week from now
Cantor Fitzgerald launched coverage of AVITA Medical (NASDAQ:RCEL) with an “overweight” rating and $23 target price. The stock closed at $15.71 on June 26 BioTuesdays on LinkedIn: …
linkedin.com
OFF
BioTuesdays On LinkedIn: Cantor Starts LifeMD At OW; PT $7
1 week from now
Cantor Fitzgerald initiated coverage of LifeMD (NASDAQ:LFMD) with an “overweight” rating and price target of $7. The stock closed at $3.53 on July 20 BioTuesdays on LinkedIn: Cantor …
linkedin.com
OFF
Markets - BioTuesdays
1 week from now
Cantor Fitzgerald launch coverage of France-based Transgene (TNG:PA) with an “overweight” rating and a 12-month price target of €4. ... Cantor starts Outlook Therapeutics at OW; PT $4. …
biotuesdays.com
OFF
BioTuesdays On LinkedIn: Cantor Starts Disc Medicine At OW; PT …
1 week from now
Cantor Fitzgerald launched coverage of Disc Medicine(NASDAQ:IRON) with an “overweight” rating and 12-month price target of $45. The stock closed at $32.24 on…
linkedin.com
OFF
AGP Starts Hepion At Buy; PT $4 - BioTuesdays
1 week from now
Feb 1, 2023 · Mr. Molloy also said Hepion is targeting a Phase 2 trial start for HCC in the first half of 2023. HCC is the most common type of primary liver cancer accounting for 85% to 90% of …
biotuesdays.com
OFF
BioTuesdays On LinkedIn: Cantor Starts Editas Medicine At OW; PT …
1 week from now
Cantor Fitzgerald initiated coverage of Editas Medicine (NASDAQ:EDIT) with an “overweight” rating and 12-month price target of $15. The stock closed at $9.35… BioTuesdays on …
linkedin.com
OFF
BioTuesdays Na LinkedIn: Cantor Starts MindMed At OW; PT $3
1 week from now
Cantor Fitzgerald launched coverage of MindMed (NASDAQ:MNMD) with an “overweight” rating and price target of $3. The stock closed at 58 cents on Aug. 9. BioTuesdays na LinkedIn: …
linkedin.com
OFF
BioTuesdays On LinkedIn: Cantor Starts X4 Pharma At OW; PT $3
1 week from now
Cantor Fitzgerald launched coverage of X4 Pharmaceuticals (NASDAQ:XFOR) with an “overweight” rating and a 12-month price target of $3. The stock closed at 80… BioTuesdays …
linkedin.com
OFF
Cantor Ups Precigen PT After R&D Event - BioTuesdays
1 week from now
Jan 30, 2023 · Cantor Fitzgerald raised its price target for Precigen (NASDAQ:PGEN) to $10 from $7 after the company held an R&D event to showcase safety and efficacy data from a Phase 1 …
biotuesdays.com
OFF
Cantor Starts AVITA Medical At OW; PT $23 - BioTuesdays
1 week from now
Jun 27, 2023 · Cantor Fitzgerald launched coverage of AVITA Medical (NASDAQ:RCEL) with an “overweight” rating and $23 target price. The stock closed at $15.71 on June 26. Avita is a …
biotuesdays.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
